| Secondary |
| Eye Disorder |
55.6% |
| Glaucoma |
22.2% |
| Open Angle Glaucoma |
16.7% |
| Smoking Cessation Therapy |
5.6% |
|
| Venous Thrombosis |
28.6% |
| Vision Blurred |
28.6% |
| Eye Infection |
14.3% |
| Middle Insomnia |
14.3% |
| Unevaluable Event |
14.3% |
|
| Concomitant |
| Hypertension |
11.2% |
| Smoking Cessation Therapy |
10.1% |
| Glaucoma |
9.6% |
| Product Used For Unknown Indication |
8.0% |
| Diabetes Mellitus |
7.4% |
| Drug Use For Unknown Indication |
7.4% |
| Blood Cholesterol Increased |
4.8% |
| Eye Disorder |
4.8% |
| Blood Pressure |
4.3% |
| Type 2 Diabetes Mellitus |
4.3% |
| Anxiety |
3.7% |
| Osteoporosis |
3.7% |
| Bipolar Disorder |
3.2% |
| Psoriasis |
3.2% |
| Dry Eye |
2.7% |
| Neuropathy Peripheral |
2.7% |
| Pain |
2.7% |
| Agitation |
2.1% |
| Atrial Fibrillation |
2.1% |
| Back Pain |
2.1% |
|
| Weight Increased |
14.7% |
| Pain |
8.0% |
| Urinary Tract Infection |
8.0% |
| Vision Blurred |
6.7% |
| Nausea |
5.3% |
| Somnolence |
5.3% |
| Visual Impairment |
5.3% |
| Atrial Fibrillation |
4.0% |
| Drug Ineffective |
4.0% |
| Eye Operation |
4.0% |
| Rotator Cuff Syndrome |
4.0% |
| Syncope |
4.0% |
| Ventricular Extrasystoles |
4.0% |
| Visual Acuity Reduced |
4.0% |
| Vomiting |
4.0% |
| Weight Decreased |
4.0% |
| Back Pain |
2.7% |
| Blood Glucose Increased |
2.7% |
| Cardio-respiratory Arrest |
2.7% |
| Cataract |
2.7% |
|
| Interacting |
| Back Disorder |
12.5% |
| Cataract |
12.5% |
| Cataract Operation |
12.5% |
| Convulsion |
12.5% |
| Glaucoma |
12.5% |
| Headache |
12.5% |
| Migraine |
12.5% |
| Neuropathy Peripheral |
12.5% |
|
| Eye Irritation |
50.0% |
| Palpitations |
50.0% |
|
